Current therapeutic strategies for T2DM management prioritize metformin as the first-line pharmacological intervention, primarily through its dual mechanisms of suppressing hepatic gluconeogenesis and enhancing peripheral glucose utilization in skeletal muscle tissue 3,4
IgG is an aging factor that drives adipose tissue fibrosis and metabolic decline
Research has shown that AOD-9604 has an extraordinary ability to target these stubborn areas specifically
With the potential to revolutionize treatments for diabetes and obesity, this novel drug is making waves
The key question for investors is whether these new categories can meaningfully offset the pressure in weight management and whether HIMS can build durable, compliant businesses in these segments
Now, seeing myself in the same green top, paired with ripped jeans, glasses, and a necklace, smiling with my arms raised it truly captures the positive change